Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.

Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 11, 2026, 11:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 1,002 matching trials from the live ClinicalTrials.gov search.
Filters: Sponsor: Abbott Clear all
Completed No phase listed Observational Results available

Human Use Condition Study- Evaluation of Implanted Leads in Humans

NCT04320849
View directory record Official record
Conditions
Pacemaker Malfunction
Interventions
Not listed
Lead sponsor
Duke University
Other
Eligibility
18 Years and older
Enrollment
117 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2022
U.S. locations
5
States / cities
Los Angeles, California • Des Moines, Iowa • Saint Paul, Minnesota + 2 more
Source: ClinicalTrials.gov public record
Updated Jan 19, 2024 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Phase 2 Interventional

A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00528697
View directory record Official record
Conditions
Attention-Deficit/Hyperactivity Disorder
Interventions
ABT-089, atomoxetine, placebo
Drug
Lead sponsor
AbbVie (prior sponsor, Abbott)
Industry
Eligibility
6 Years to 12 Years
Enrollment
278 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2008
U.S. locations
20
States / cities
Little Rock, Arkansas • El Centro, California • Boulder, Colorado + 17 more
Source: ClinicalTrials.gov public record
Updated Jan 29, 2013 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Not applicable Interventional

Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)

NCT00206843
View directory record Official record
Conditions
Heart Failure
Interventions
Triage BNP Test
Device
Lead sponsor
Abbott RDx Cardiometabolic
Other
Eligibility
18 Years and older
Enrollment
630 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2004 – 2007
U.S. locations
10
States / cities
Chandler, Arizona • San Diego, California • Detroit, Michigan + 6 more
Source: ClinicalTrials.gov public record
Updated Jul 27, 2015 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Phase 2 Interventional

Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00640185
View directory record Official record
Conditions
Attention-Deficit/Hyperactivity Disorder
Interventions
ABT-089, Placebo
Drug
Lead sponsor
AbbVie (prior sponsor, Abbott)
Industry
Eligibility
18 Years to 60 Years
Enrollment
160 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008
U.S. locations
12
States / cities
Lafayette, California • Jacksonville, Florida • Orlando, Florida + 9 more
Source: ClinicalTrials.gov public record
Updated Jan 18, 2013 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Not applicable Interventional Results available

Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter

NCT01408485
View directory record Official record
Conditions
Typical Atrial Flutter
Interventions
Therapy™ Cool Flex™ Irrigated Ablation System
Device
Lead sponsor
Abbott Medical Devices
Industry
Eligibility
18 Years and older
Enrollment
200 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2012
U.S. locations
22
States / cities
Phoenix, Arizona • Oakland, California • Pasadena, California + 19 more
Source: ClinicalTrials.gov public record
Updated Feb 15, 2019 · Synced Oct 11, 2026, 11:56 PM EDT
Completed No phase listed Observational

FreeStyle Libre Flash Glucose Monitoring System Accuracy

NCT03159546
View directory record Official record
Conditions
Diabete Mellitus
Interventions
Device: FreeStyle Libre Flash Glucose Monitoring System
Device
Lead sponsor
Abbott Diabetes Care
Industry
Eligibility
18 Years and older
Enrollment
50 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017
U.S. locations
4
States / cities
Santa Barbara, California • Walnut Creek, California • Idaho Falls, Idaho + 1 more
Source: ClinicalTrials.gov public record
Updated Sep 6, 2017 · Synced Oct 11, 2026, 11:56 PM EDT
Terminated Phase 3 Interventional Results available

The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5

NCT00616902
View directory record Official record
Conditions
Chronic Kidney Disease (CKD) Stage 5, Hypertrophy, Left Ventricular
Interventions
paricalcitol injection 4 mcg/mL, Placebo Injection 4 mcg/mL
Drug
Lead sponsor
Abbott
Industry
Eligibility
18 Years and older
Enrollment
12 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009
U.S. locations
29
States / cities
Phoenix, Arizona • Tempe, Arizona • Bakersfield, California + 24 more
Source: ClinicalTrials.gov public record
Updated Jan 20, 2012 · Synced Oct 11, 2026, 11:56 PM EDT
Recruiting Not applicable Interventional

Deep Brain Stimulation Effects In Patients With Opioid Use Disorder

NCT04354077
View directory record Official record
Conditions
Opioid-use Disorder
Interventions
DBS of the NAc
Device
Lead sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Other
Eligibility
22 Years to 65 Years
Enrollment
3 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2030
U.S. locations
1
States / cities
Pittsburgh, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Aug 31, 2026 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Phase 3 Interventional Results available

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

NCT00566722
View directory record Official record
Conditions
Psoriasis
Interventions
adalimumab
Biological
Lead sponsor
Abbott
Industry
Eligibility
18 Years and older
Enrollment
152 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008 – 2009
U.S. locations
18
States / cities
Birmingham, Alabama • Little Rock, Arkansas • San Diego, California + 13 more
Source: ClinicalTrials.gov public record
Updated Apr 12, 2011 · Synced Oct 11, 2026, 11:56 PM EDT
Completed No phase listed Observational

Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical SWIFT HM3 PMS

NCT04548128
View directory record Official record
Conditions
Advanced Refractory Left Ventricular Heart Failure
Interventions
HeartMate 3 Left Ventricular Assist System (HM3 LVAS)
Device
Lead sponsor
Abbott Medical Devices
Industry
Eligibility
18 Years and older
Enrollment
102 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2022
U.S. locations
31
States / cities
Little Rock, Arkansas • Palo Alto, California • Aurora, Colorado + 26 more
Source: ClinicalTrials.gov public record
Updated Feb 1, 2023 · Synced Oct 11, 2026, 11:56 PM EDT
Terminated Phase 3 Interventional Accepts healthy volunteers

Growth and Tolerance of Healthy Term Infants to a New Infant Formula

NCT01137877
View directory record Official record
Conditions
Healthy Term Infants
Interventions
Milk based infant formula powder, Investigational Infant Formula #1, Investigational Infant Formula #2, Human Milk
Other
Lead sponsor
Abbott Nutrition
Industry
Eligibility
1 Day to 11 Days
Enrollment
399 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2010
U.S. locations
20
States / cities
Little Rock, Arkansas • Mission Hills, California • Norwich, Connecticut + 17 more
Source: ClinicalTrials.gov public record
Updated Nov 25, 2010 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Not applicable Interventional

Does Echocardiographically Guided Ventriculo-Ventricular Optimization Yield a Sustained Improvement in Echocardiographic Parameters in Cardiac Resynchronization Therapy Patients? (DEVISE CRT)

NCT00737490
View directory record Official record
Conditions
Cardiomyopathy, Heart Failure
Interventions
"Sequential Arm" (Promote , model # 2207-36 or Atlas HF , model # V-343), "Simultaneous Arm" (Promote , model # 2207-36 or Atlas HF , model # V-343)
Other
Lead sponsor
Duke University
Other
Eligibility
18 Years and older
Enrollment
40 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2005 – 2011
U.S. locations
1
States / cities
Durham, North Carolina
Source: ClinicalTrials.gov public record
Updated Aug 1, 2014 · Synced Oct 11, 2026, 11:56 PM EDT
Not listed Not applicable Interventional Accepts healthy volunteers

A Clinical Assessment of the Full Range of Functional Vision With Three Tecnis Multifocal IOL 1-Piece Models in Bilateral Cataract Extraction

NCT02863159
View directory record Official record
Conditions
Cataract
Interventions
Tecnis Multifocal 1-Piece IOL
Device
Lead sponsor
Dell Laser Consultants
Other
Eligibility
21 Years and older
Enrollment
100 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2015 – 2017
U.S. locations
1
States / cities
Austin, Texas
Source: ClinicalTrials.gov public record
Updated Aug 11, 2016 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Phase 4 Interventional Results available

Kaletra Sex/Gender Pharmacokinetics (PK) Study

NCT00148759
View directory record Official record
Conditions
HIV Infections
Interventions
LPV/r
Drug
Lead sponsor
Emory University
Other
Eligibility
18 Years and older
Enrollment
23 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2005 – 2007
U.S. locations
1
States / cities
Atlanta, Georgia
Source: ClinicalTrials.gov public record
Updated Dec 3, 2013 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Phase 4 Interventional Results available

Effect of Valproic Acid Concentration on Photic Response

NCT00609245
View directory record Official record
Conditions
Photosensitive Epilepsy
Interventions
Valproic Acid, Placebo
Drug
Lead sponsor
Vanderbilt University Medical Center
Other
Eligibility
15 Years to 65 Years
Enrollment
13 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2008
U.S. locations
2
States / cities
Chesterfield, Missouri • Nashville, Tennessee
Source: ClinicalTrials.gov public record
Updated Jun 14, 2017 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Not applicable Interventional

A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients

NCT00002201
View directory record Official record
Conditions
HIV Infections
Interventions
Ritonavir, Nelfinavir mesylate
Drug
Lead sponsor
Abbott
Industry
Eligibility
12 Years and older
Healthy volunteers
Healthy volunteers not accepted
U.S. locations
1
States / cities
Baltimore, Maryland
Source: ClinicalTrials.gov public record
Updated Feb 20, 2009 · Synced Oct 11, 2026, 11:56 PM EDT
Terminated Not applicable Interventional Accepts healthy volunteers

Oral Rehydration Solutions in Healthy Adult Athletes

NCT05569044
View directory record Official record
Conditions
Hydration
Interventions
Control Group, Oral Rehydration Solution, Water
Other
Lead sponsor
Abbott Nutrition
Industry
Eligibility
18 Years to 30 Years
Enrollment
23 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2024
U.S. locations
1
States / cities
Kent, Ohio
Source: ClinicalTrials.gov public record
Updated Sep 19, 2024 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Phase 1Phase 2 Interventional Results available

Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer

NCT00113334
View directory record Official record
Conditions
Head and Neck Cancer
Interventions
ABT-510
Drug
Lead sponsor
M.D. Anderson Cancer Center
Other
Eligibility
18 Years and older
Enrollment
6 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2005 – 2008
U.S. locations
1
States / cities
Houston, Texas
Source: ClinicalTrials.gov public record
Updated Aug 7, 2014 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Phase 3 Interventional

A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.

NCT00195754
View directory record Official record
Conditions
Migraines
Interventions
divalproex sodium
Drug
Lead sponsor
Abbott
Industry
Eligibility
12 Years to 17 Years
Enrollment
114 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
Started 2004
U.S. locations
1
States / cities
North Chicago, Illinois
Source: ClinicalTrials.gov public record
Updated Jul 31, 2007 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Phase 2 Interventional

A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00391729
View directory record Official record
Conditions
Attention-Deficit/Hyperactivity Disorder
Interventions
ABT-089, Placebo
Drug
Lead sponsor
Abbott
Industry
Eligibility
18 Years to 60 Years
Enrollment
221 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2006 – 2007
U.S. locations
23
States / cities
Mesa, Arizona • Lafayette, California • Oceanside, California + 20 more
Source: ClinicalTrials.gov public record
Updated Oct 18, 2011 · Synced Oct 11, 2026, 11:56 PM EDT
Completed No phase listed Observational Results available

Advance Cardiac Resynchronization Therapy (CRT) Registry

NCT01805154
View directory record Official record
Conditions
Heart Failure
Interventions
CRT Patients
Device
Lead sponsor
Abbott Medical Devices
Industry
Eligibility
18 Years and older
Enrollment
1,529 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2017
U.S. locations
41
States / cities
Birmingham, Alabama • Huntsville, Alabama • Glendale, Arizona + 36 more
Source: ClinicalTrials.gov public record
Updated Aug 12, 2019 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Phase 3 Interventional

Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects

NCT00043966
View directory record Official record
Conditions
HIV Infections
Interventions
Lopinavir/ritonavir, Tenofovir DF, Emtricitabine
Drug
Lead sponsor
Abbott
Industry
Eligibility
18 Years and older
Enrollment
200 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
Started 2002
U.S. locations
29
States / cities
Phoenix, Arizona • Beverly Hills, California • Fountain Valley, California + 23 more
Source: ClinicalTrials.gov public record
Updated Jul 27, 2006 · Synced Oct 11, 2026, 11:56 PM EDT
Terminated Phase 3 Interventional

Study of Blood Concentrations and Physiologic Effects of Levosimendan Given During Heart Surgery

NCT00166127
View directory record Official record
Conditions
Heart Failure
Interventions
Levosimendan
Drug
Lead sponsor
Emory University
Other
Eligibility
21 Years to 80 Years
Enrollment
1 participant
Healthy volunteers
Healthy volunteers not accepted
Timeline
2005 – 2007
U.S. locations
1
States / cities
Atlanta, Georgia
Source: ClinicalTrials.gov public record
Updated Nov 15, 2013 · Synced Oct 11, 2026, 11:56 PM EDT
Completed Not applicable Interventional Results available

TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater TR

NCT03227757
View directory record Official record
Conditions
Tricuspid Valve Insufficiency
Interventions
Tricuspid Valve Repair System
Device
Lead sponsor
Abbott Medical Devices
Industry
Eligibility
18 Years to 90 Years
Enrollment
98 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2024
U.S. locations
4
States / cities
Los Angeles, California • Detroit, Michigan • Minneapolis, Minnesota + 1 more
Source: ClinicalTrials.gov public record
Updated Nov 6, 2024 · Synced Oct 11, 2026, 11:56 PM EDT